Chronic myelogenous leukemia (CML) which is resulted from the BCR-ABL tyrosine kinase (TK) chimeric oncoprotein, is a malignant clonal disorder of hematopoietic stem cells. The gene discussed is TKT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.